Clinical Trials on Dopamine in China
Total 1 results
-
Affiliated Hospital to Academy of Military Medical...CompletedUlcerative Colitis | Dopamine Dysregulation SyndromeChina
Sponsors and Collaborators
- Michael J. Wesley, PhD
- King Baudouin Foundation
- Walgreens Co.
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- HeartPoint Global
- Korrus Inc.
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Laboratorios Viñas, S.A.
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Pharmaspecific
- Edanz Group Japan Ltd
- Gulsah Ilhan
- Frankel, Amylynne, M.D.
- Center for Rare Neurological Diseases, Norcross, GA
- Ana Paula Costella
- Fundación Pública Andaluza Progreso y Salud
- Ruba Musharbash Nutrition Consultancy Center
- Manmohan Cardiothoracic Vascular and Transplant Center
- Army Hospital, Percy
- IRCCS Don Gnocchi, Milano, Italy
- View Full List
Medical Conditions
- Developmental Language Disorder and Language Impairment
- Gastroenteritis Rotavirus
- Menopause
- Uncontrolled Type 2 Diabetes Mellitus
- Impairment, Coordination
- Severe Atopic Dermatitis
- Malignant Intracranial Germ Cell Tumor
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Localized Unresectable Adult Primary Liver Cancer
- Cognitive Function, Social 1
- Pelvis Tumors
- Lung Neuroendocrine Tumor
- Ankylosed Teeth
- Paralysis of Vocal Cords or Larynx
- Brain Arteriovenous Malformation
- Coagulation Disorder Neonatal
- Cardiovascular Outcomes
- Kidney Damage
- Facial Involvement
- View Full List
Drug Interventions
- CD25 treatment
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Thiotepa
- Insulin
- Extended release guanfacine
- Transdermal estradiol
- LDEPA
- FHND5071
- Lidocaine/ ketamine
- Apremilast
- Interferon beta-1b (Betaferon, BAY86-5046)
- Ozanimod
- Methotrexate
- Interleukin-2
- Rituximab plus CHOP
- Exendin 9-39
- Dexmedetomidine
- Miglustat
- 5-Fluorouracil
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Chile
- Contract Research Organizations in Croatia
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Guinea
- Contract Research Organizations in Kenya
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in South Africa
- Contract Research Organizations in Sweden
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in United Kingdom
- CRO list by country